Hepatopancreatobiliary Surgery (HPB) — Specialty Profile

Exploratory, not prescriptive. This profile blends hard data (pay, match rates, burnout, demographics, each sourced and dated) with generalizations and synthesized opinion about culture and "who fits." It's here to help you get curious and go find out for yourself, not to tell you who to become. Numbers marked ⟳ verify change every year; check the linked source before you quote one. Last reviewed: 2026-08-04.

Also called: HPB, hepatobiliary surgery, liver and pancreas surgery, "the Whipple people." A 1–2 year fellowship entered after a general surgery residency, not a residency you match into from medical school. Organ systems: liver, pancreas, bile ducts, and gallbladder, mostly for cancer.

Subspecialty fellowship of General Surgery.

The 30-second version

HPB surgery is where general surgery keeps its biggest operations: the liver, the pancreas, and the bile ducts, organs that bleed catastrophically, heal badly, and sit wrapped around the vessels that feed the entire abdomen. The signature case is the pancreaticoduodenectomy, the Whipple, in which you remove the head of the pancreas, the duodenum, the gallbladder, and the bile duct in one specimen and then rebuild the gastrointestinal tract from three separate anastomoses. It takes most of a day. The other half of the field is liver resection, where the operative problem is that the liver has no natural planes and every surface you cut is a potential hemorrhage. What makes HPB unusual among the surgical subspecialties is that the field is defined by an anatomical territory rather than by a training program: there are three different doors into it, none of them ACGME-accredited on the HPB side, and the surgeons who walk through them end up doing much the same job. The trade at the center of the field: you get the most technically demanding elective operations in general surgery, mostly scheduled rather than emergent, in exchange for a long training tail, a job market that its own graduates describe as oversaturated, and a patient population where pancreatic cancer means many of your best operations still end badly.

Quick dashboard (details and sources below)
Training after med school 6–7 years (5 yr general surgery + 1–2 yr HPB fellowship), commonly 8–9 with research years
Total from college start ~15 years (4 undergrad + 4 med school + 5 residency + 2 fellowship), often 16–17
Training chain Med school (4) → General Surgery (5) → HPB fellowship (2), or reach the same practice via ACGME surgical oncology or abdominal transplant
Competitiveness (as a surgical fellowship) No published match rate; the Fellowship Council does not release HPB statistics publicly. Small field, roughly 20 US programs, connection-sensitive ⟳
Typical full-time pay No HPB-specific survey exists. Bracketed by general surgery at $482,574 (Doximity 2025) and, in the only peer-reviewed subspecialty data, surgical oncology at $473,343–$499,141 and transplant at $557,861–$603,002 (MGMA 2022) ⟳
Lifestyle Long elective operative days, sick postoperative patients, lighter emergency burden than trauma or transplant
Burnout No HPB-specific figure; inherit general surgery at ~43.8% (2025), near the all-physician average ⟳
% women No clean HPB figure; AHPBA membership ran ~86% male in a 2014 survey; parent general surgery 24% practicing, 49.9% of residents ⟳
DO / IMG accessibility Gated behind general surgery (19.1% DO, 11.8% IMG of categorical positions filled, 2026 Match); international fellows are a real presence at HPB programs ⟳

What they actually do

HPB surgeons operate on the liver, pancreas, biliary tree, and gallbladder, and the great majority of that work is cancer or the consequences of cancer. The bread and butter is pancreatic adenocarcinoma, cholangiocarcinoma, gallbladder cancer, hepatocellular carcinoma, and colorectal metastases to the liver, plus a substantial benign practice in chronic pancreatitis, complex biliary injury, cystic pancreatic lesions, and neuroendocrine tumors.12

Two operations define the territory. The pancreaticoduodenectomy, universally called the Whipple, removes the head of the pancreas along with the duodenum, gallbladder, and distal bile duct, and then reconstructs three connections: pancreas to bowel, bile duct to bowel, and stomach to bowel. The pancreatic anastomosis is the one that keeps surgeons awake, because a leak there produces a pancreatic fistula, and enzymatic fluid loose in the abdomen digests the tissue and vessels around it. The second is hepatectomy, anatomic or non-anatomic liver resection, where the technical problem is that the liver is a solid organ with no bloodless plane, so the entire operation is an exercise in controlling inflow, outflow, and parenchymal transection without losing the patient's circulating volume.13

Representative procedures and hands-on work: pancreaticoduodenectomy, open, laparoscopic, and increasingly robotic · distal pancreatectomy and total pancreatectomy · major hepatectomy (right, left, extended) and segmentectomy · portal vein and arterial resection with reconstruction for locally advanced tumors · biliary reconstruction, including repair of bile duct injuries from cholecystectomy · operative and endoscopic management of chronic pancreatitis and necrotizing pancreatitis · intraoperative ultrasound, which HPB surgeons perform and read themselves · ablation and hepatic artery infusion pump placement for liver metastases.1

A day in the life: mostly scheduled and mostly long. A typical operative day is one big case, or one big case and one medium one, starting early and running into the afternoon or evening. Between operative days there is clinic, and HPB clinic is unusual in how much of it is decision-making rather than procedure-booking: a large fraction of patients referred for a Whipple should not have one, because the tumor involves vessels it should not, or because the patient will not survive the recovery, and sorting that out is a real part of the job. Multidisciplinary tumor board is a fixed weekly commitment. The rest of the week is inpatient care of postoperative patients who are genuinely sick, since the complications of this field, fistula, delayed gastric emptying, hemorrhage from an eroded artery, liver failure after a large resection, arrive on days three through ten rather than in the OR.

The emergency burden is lighter than trauma or transplant. You are not being called in for organ offers at 2 a.m., and you are not covering an acute care surgery service unless your job description says so. What you do carry is your own complications, and when a postoperative pancreatic fistula bleeds, it bleeds at night and it is yours.

The training path & time to completion

Medical school (4 yrs) → general surgery residency (5 yrs, often with 1–2 additional research years at academic programs) → HPB fellowship (1–2 yrs, with 2 the strong norm) → practice.14

This is the part that confuses people, so take it slowly: there are three separate doors into the same practice, and only two of them produce an ABS board certificate.

  • Dedicated HPB fellowship. Two years, accredited jointly by the Fellowship Council and the Americas Hepato-Pancreato-Biliary Association (AHPBA), matched through the Fellowship Council. It is not ACGME-accredited, and completing it makes you eligible for AHPBA HPB certification rather than for an American Board of Surgery subspecialty certificate. Eligibility is completion of a US or Canadian general surgery residency; international graduates need ECFMG certification and usually H-1B or O-1 sponsorship.1
  • Complex General Surgical Oncology (CGSO). Two years, ACGME-accredited, leading to a genuine ABS board certification. Many CGSO programs are HPB-heavy by design, and graduates can pursue AHPBA HPB certification on top of the ABS certificate, which is the dual-credential route.2 The parent surgical oncology profile covers this pathway in full.
  • Abdominal transplant surgery. Two years, ASTS-accredited. Transplant surgeons operate on the liver constantly and many build a large elective HPB practice alongside transplant, which is also, as the transplant surgery profile documents, the main lever that moves a transplant salary toward the top of its range.5

The AHPBA certificate process began in 2010, which is recent enough that a substantial share of practicing HPB surgeons trained before any of this was formalized.4 A 2014 AHPBA survey found its own membership split almost evenly across the doors: 28% came through surgical oncology, 24.8% through transplant, 24.2% through a dedicated HPB fellowship, 16% through combined HPB/complex GI, and 4% through HPB/MIS.4 ⟳

Fellowship length is a live question inside the field rather than a settled fact. In that same survey, 68.1% preferred a two-year clinical fellowship with research opportunities, and 67.5% of already-practicing surgeons agreed. One-year programs exist and one-year graduates practice, but the field's own preference is clear.4

Total from the start of college: about 15 years (4 undergrad + 4 med school + 5 residency + 2 fellowship). At academic programs where a research block is expected, 16 to 17 is common, and a meaningful minority arrive later still: 58% of HPB fellowship graduates surveyed across 2010–2019 had already completed a different fellowship before starting HPB.6 That statistic carries real weight, because it means a large share of this field did seven or eight postgraduate years before beginning the training that defines their career.

On volume, and why the numbers are the whole argument. The AHPBA survey asked how many cases a trainee needs before independent practice. For pancreaticoduodenectomy, respondents said 29, and trainees reported averaging 38 during fellowship. For hemi-hepatectomy, 27.4 Those thresholds are not arbitrary. They exist because the volume-outcome relationship in pancreatic surgery is among the strongest in all of surgery, and it is the reason the fellowship exists at all.

How competitive is it?

Start with an honest limitation: there is no published HPB match rate. The Fellowship Council runs the match and keeps its matching statistics behind a login, so unlike the NRMP fields or even the SF Match specialties, no applicant-to-position ratio is publicly verifiable. Anyone quoting one to you is estimating.1

What can be said with sources:

  • The field is small. A 2014 count put it at roughly 20 HPB fellowship programs in the United States and 6 in Canada, most offering one or two positions.4 That figure is over a decade old and the program list has grown, so treat the exact number as stale, but the order of magnitude has not changed: this is a field of dozens of fellows per year, not hundreds. ⟳
  • The hard filter is upstream. You must first complete a general surgery residency, which is its own five-year selection, and the parent general surgery profile documents an attrition rate around 20% before anyone reaches a fellowship application at all.
  • Applicants arrive heavily credentialed. With 58% having already done another fellowship and academic programs expecting research output, the applicant pool self-selects hard.6
  • The three-door structure changes what "competitive" means. Because CGSO and transplant both lead to HPB practice, an applicant who does not match a dedicated HPB spot has genuine alternative routes to the same operating room. That is unusual, and it makes the field less of a single bottleneck than the raw position count suggests.

The honest read. Competitiveness here is about scarcity and connections rather than a published gauntlet. Positions are few, programs are concentrated at high-volume academic centers, and mentorship inside a strong HPB division is the thing that gets people in. The gate that actually hurts comes after graduation rather than at the application, and it is covered under compensation below.

Board status: the dedicated HPB fellowship yields AHPBA HPB certification, a society credential rather than an ABMS board. The CGSO route yields an ABS subspecialty certificate. That distinction matters for academic appointments and for some hospital credentialing, and it is a genuine argument in favor of the CGSO door if you want the formal board.12

Compensation — the robust version

The headline finding is that no HPB-specific compensation survey exists. MGMA, Doximity, and the major benchmark reports do not carry an "HPB surgeon" line, because the field is small and its members are coded as general surgeons, surgical oncologists, or transplant surgeons depending on how their institution files them. Every HPB salary number circulating online is either a general-surgery figure, a transplant figure, or an aggregator estimate scraped from job postings. Treat all of them accordingly.

The two defensible anchors:

  • General surgery. Doximity's 2025 report, drawn from more than 37,000 physician responses in 2024, puts general surgery at $482,574 average annual compensation.7 The parent profile's working range is ~$440,000–$485,000.8 ⟳
  • The nearest measured neighbors, from the peer-reviewed literature. A 2025 study in the Journal of the American College of Surgeons pulled MGMA provider compensation data for 2014, 2018 and 2022 and reported mean total cash compensation by surgical subspecialty and setting. For 2022 it gives transplant surgery at $557,861 academic and $603,002 non-academic, and surgical oncology at $473,343 academic and $499,141 non-academic.5 ⟳ Surgical oncology is the better proxy of the two, because 81% of complex general surgical oncology graduates go on to care for HPB patients. Neither number is an HPB figure, and the study reports no provider counts, so read them as the shape of the neighborhood.
  • One thing the literature says clearly. A separate 2025 study of 12,443 academic surgery faculty, drawn from the AAMC Faculty Salary Survey, found transplant surgery to be the lowest-paying academic surgical subspecialty.9 That cuts against how transplant and HPB are usually described to trainees, and it is the single most useful sentence about this corner of surgery's money.

What that implies, stated as an inference rather than a measurement. An HPB practice sits inside that cluster, somewhere around the high $400,000s to the high $500,000s, with the position set by case volume, elective mix, and setting rather than by the credential. Academic HPB at a university tertiary center clusters at the lower end, because the salary is a salary and protected research time is unpaid clinical time. A high-volume HPB surgeon in a hybrid or private tertiary practice sits above it. The fellowship itself does not buy a raise; the case mix it qualifies you for does.

The old number on this page was $677,090, and it was wrong in a specific way. It came from Salary.com, a job-posting aggregator, dressed as a five-point percentile ladder that ran from $550,311 at the 10th to $863,261 at the 90th. That precision was fake, the source publishes no methodology, and the peer-reviewed transplant figures above sit roughly $75,000 to $120,000 below its median. The ladder is gone and nothing replaced it, because no publisher produces a transplant or HPB distribution. If you find a confident HPB salary elsewhere on the internet, this is very likely where it came from.

Why the economics work the way they do. Whipples and major hepatectomies are among the highest-wRVU operations in general surgery, and they are elective, which means they can be scheduled, batched, and protected from the cancellation and no-show attrition that erodes emergency-heavy practices. The counterweight is that they are slow. One surgeon can do one Whipple in a day, where a general surgeon can do six laparoscopic cholecystectomies. High value per case, low cases per day, and the two roughly cancel.

The compensation risk specific to this field is the job market rather than reimbursement. An AHPBA-commissioned survey of certified fellowship graduates, run August through December 2021, found "concern for job market oversaturation" as one of its four dominant themes, with graduates describing the market as saturated by trainees emerging from all three societies at once.10 Since HPB practice requires a referral base and an institution willing to build volume around you, a saturated market does not usually show up as unemployment. It shows up as taking a job where you operate less than you trained to.

Limited-data caveat: there is no MGMA, Doximity, or AMGA line for HPB surgery, and none of the three societies whose members do this work — AHPBA, ASTS, the Society of Surgical Oncology — posts compensation data publicly. ASTS has run a Transplant Surgeon Compensation Survey since 2008, most recently fielded in June 2022, and sells it rather than publishing it, so this page cannot read it. The figures above are real and sourced; the inference between them is this site's, and any specific "HPB salary" you find elsewhere is almost certainly one of the neighboring numbers relabeled. ⟳

Lifestyle

HPB is a demanding surgical life, and the honest comparison is not against dermatology but against its own neighbors. Against trauma and transplant it is calmer. Against breast or endocrine surgery it is not.

  • Hours track general surgery's, which the parent profile puts at roughly 60–66 per week, with the distribution shaped differently: fewer nights, longer days.8 A single operative day can run eight to twelve hours from first incision to a stable patient in the ICU.
  • The work is predominantly elective and scheduled. This is the real lifestyle advantage over the other two high-acuity abdominal fields. Your OR days are known weeks ahead, your clinic is booked, and tumor board is on the calendar. You are not waiting on an organ offer or a trauma page.
  • Call is about your own patients. Coverage arrangements vary, but the recurring theme is that the after-hours burden comes from postoperative complications rather than from new emergencies. A patient bleeding from a pseudoaneurysm on postoperative day eight is a genuine middle-of-the-night emergency, and it is a patient you operated on.
  • Geographic control is poor. High-volume HPB practice exists at tertiary and quaternary centers. You can be a general surgeon almost anywhere; you cannot be a Whipple surgeon almost anywhere, because the volume-outcome data means low-volume HPB is actively worse care. This constrains where you live for your entire career, and it is the most underrated cost of the field.

Lifestyle rating: 2/5. Long operative days, sick inpatients, and heavy cognitive load in clinic, partially offset by an elective, schedulable structure and a lighter emergency burden than trauma or transplant. The schedule improves with seniority and APP support. The geographic constraint does not improve at all.

Wellbeing — the part to take seriously

No HPB-specific burnout figure has been published, so this section inherits general surgery and then names the one axis HPB genuinely changes.

Burnout inherits general surgery, which is mid-pack on both surveys that measure it. The AMA's 2025 Organizational Biopsy puts general surgery at 43.8% against a 41.9% all-physician average, with emergency medicine at 49.8% and urology at 49.5%. Medscape's 2024 report is a separate instrument with a higher baseline and puts general surgery at 45% against a 49% average. Different levels, same verdict, and the numbers should not be mixed across the two. The lesson the parent profile draws applies here either way: hours and burnout are not the same variable, and the ownership surgeons have over their work appears to buffer them against what the raw hours would predict.8 ⟳

Satisfaction with the training itself is unusually high. Among HPB fellowship graduates from 2010 through 2019, more than 90% rated their satisfaction with fellowship training above 8 out of 10, and 75% were still in their first job at the time of the survey.6 For a two-year, non-ACGME fellowship taken after five to seven years of residency, that is a strong signal that the people who do it feel the training delivered.

The distinctive emotional load is oncologic, and it is heavy. Pancreatic adenocarcinoma is the central disease of this field and it has among the worst survival of any solid tumor. You will perform a technically excellent Whipple, a genuine feat, on a patient who recurs within eighteen months. You will also spend a real fraction of your clinic telling patients that the operation they were referred for and have pinned their hope to is not going to help them. Surgeons in fields where the operation cures the disease do not carry this. HPB surgeons do, and it is closer to the emotional profile of medical oncology than to that of general surgery.

The complication load is its own stressor. Pancreatic and hepatic surgery carries a complication rate that would be unacceptable in most elective fields, and the surgeon who caused it manages it. The volume-outcome literature quantifies the stakes: in the landmark California and Florida analysis, in-hospital mortality after pancreaticoduodenectomy ran 14.6% at very-low-volume hospitals against 4.7% at high-volume hospitals in the earliest period studied, and 9.5% against 3.3% by 1996–1998.3 Modern high-volume centers report lower still. Those are the numbers behind the field's insistence on volume, and they are also the numbers a fellow internalizes about what happens when they are not good enough. ⟳

What the field says about its own training. The AHPBA SWOT survey of certified graduates named the strengths as case volume, knowledge, and mentorship, and the weaknesses as a lack of standardization between programs, so that what a graduating HPB surgeon is prepared to do varies by where they trained.10 If you are choosing programs, that variability is the thing to interrogate, and case logs are the only honest way to do it.

Who's in the field (demographics)

HPB-specific demographic data is thin, and what exists is dated. Where a figure is missing, the parent general surgery numbers are the best available.

  • Women: underrepresented, on the limited evidence available. The 2014 AHPBA symposium survey of the society's own membership was 86.2% male, though that reflects an established workforce (half the respondents were more than five years out of training) rather than the current trainee pipeline.4 Parent general surgery runs 24% women practicing (AAMC, 2022 data) against 49.9% of residents (ACGME, AY2024-25), so the pipeline has reached parity even where the practicing workforce has not.8 No current HPB fellow gender breakdown is published. ⟳
  • Underrepresented in medicine: the AHPBA's own graduate survey named "importance of diversity, inclusion, and equity in HPB training" as one of four dominant themes, which is a society acknowledging a gap rather than a measurement of it.10 No reliable HPB URiM percentage exists. Inherit general surgery's, and treat the field as more concentrated than its parent, because academic tertiary centers are the whole employment base. ⟳
  • DO: low. Gated behind general surgery, which filled 19.1% of its categorical positions with DO graduates in the 2026 Match, and then behind academic fellowship selection, which tilts toward university programs.8 No HPB-specific figure. ⟳
  • IMG: a real presence, unusually so for a surgical subspecialty. Multiple HPB programs explicitly sponsor H-1B and O-1 visas and several major centers run separate international HPB fellowships.1 Parent general surgery filled 11.8% of its categorical positions with international graduates in the 2026 Match.8 ⟳

Culture, personality & the online stereotypes

Who gravitates here: general surgery residents who found that the biggest, longest, most anatomically demanding cases were the ones they wanted more of. There is a strong technical-perfectionist streak, since the difference between a good and a bad pancreatic anastomosis is measured in complications, and everyone in the field knows it. It also draws people who like oncology as an intellectual problem, because a large share of the job is deciding who should be operated on rather than operating. Academic orientation is close to a given, since the jobs are at academic centers. As always, plenty of people in the field do not fit any single mold.

The stereotypes. Community perception rather than fact, each with a kernel and an unfair edge:

  • "The Whipple club." The read is that HPB surgeons are the ones who wanted the hardest operation in the abdomen and organize their identity around it. There is truth in the pride, and the operation genuinely is a marathon, but the caricature misses how much of the actual week is clinic, tumor board, and postoperative management.
  • "A fellowship that isn't a board." The pointed version of a real structural fact: the dedicated HPB fellowship is non-ACGME and confers a society certificate. People who took the CGSO route sometimes say this loudly. The counter is that AHPBA-certified programs are held to case-volume standards and that the operating room does not check your certificate.
  • "Three societies, one job, too many graduates." The oversaturation critique, and this one has data behind it rather than only sentiment, since the AHPBA's own graduate survey found exactly this concern as a dominant theme.10 It is a live controversy in the field, not a jab.
  • "You train for eight years to do an operation that doesn't cure anyone." The cruelest version of the pancreatic-cancer survival problem. Unfair, since resection remains the only path to cure and the field has meaningfully improved perioperative mortality, but it names something real that HPB surgeons think about.

What people say online (synthesized and paraphrased, not quotes): across trainee and physician forums, and the surgical corners of medical Twitter, the recurring HPB threads are about the door problem and the job problem. On doors, the most common question is whether to pursue dedicated HPB, CGSO, or transplant, and the most common answer is that CGSO carries the ABS board and transplant carries the widest job options, while dedicated HPB carries the most focused case volume. On jobs, the consistent warning is that the credential does not create the practice, and that a new HPB surgeon needs an institution with referral volume and a senior partner willing to share it, or they will spend their first years doing general surgery with an HPB title. Robotics comes up constantly, with the fault line running between surgeons who consider a robotic Whipple the direction of the field and those who consider it a solution looking for a problem. The tone overall is proud of the operations, clear-eyed about the market, and openly frustrated about the lack of standardization.

Voices from the field. Paraphrased from published work, with links to the originals:

  • The AHPBA-commissioned SWOT analysis of certified fellowship graduates, run in late 2021, distilled the field's own view into four themes: curricula are not standardized, the job market feels oversaturated, the value of HPB training needs articulating, and equity in training matters. Its summary line is that HPB training excellence means volume, knowledge, and mentorship.10
  • A survey of HPB fellowship graduates from 2010 to 2019 found the outcome side more reassuring than the sentiment: 82% received one to three job offers during fellowship, more than 60% secured a job with a majority-HPB practice and more than 40 HPB cases per year within three years, and more than 90% rated the training above 8 out of 10.6
  • The 2014 AHPBA residents' and fellows' symposium survey documented the three-door structure quantitatively and established the field's preference for a two-year clinical fellowship, along with the case-number thresholds trainees and faculty consider necessary for independence.4

Why people choose it / why people leave

Why choose it: the most technically demanding elective operations in general surgery, and the anatomy that makes them demanding is genuinely beautiful to work in · a case mix that is scheduled rather than emergent, which is a real quality-of-life gain over trauma and transplant · oncologic decision-making as a substantial and intellectually serious part of the job · multidisciplinary practice where you are a peer of medical and radiation oncology rather than a technician they consult · training satisfaction that graduates rate very highly · a clear volume-outcome literature, which means your skill measurably changes whether patients live.

Why leave or avoid it: a job market its own society describes as oversaturated, where the risk is under-operating rather than unemployment · geographic constraint for an entire career, since low-volume HPB is worse care and the jobs are at tertiary centers · a very long training tail, 15 years from the start of college and often 16 or 17, with 58% of graduates having done a prior fellowship · the emotional weight of pancreatic cancer outcomes, which no amount of technical excellence fixes · a complication profile you personally own and personally manage · a credential structure where the dedicated route is non-ACGME and does not produce an ABS board.

Best fit if: the longest and hardest cases were the ones you wanted more of in residency · you want cancer surgery where the decision to operate is as hard as the operation · you are willing to organize your geography around where the volume is · you are comfortable in academic and tertiary settings · you can hold a career-long tension between doing excellent work and losing patients anyway.

Not for you if: you want geographic freedom · you need a defined, published competitiveness ladder and a board certificate at the end · you want a shorter path to attending life, since 15-plus years is the floor · high-complication, high-stakes elective surgery would erode you · you would rather operate on more patients per week than on harder problems.

The FLI angle — Hepatopancreatobiliary surgery for first-gen, low-income & immigrant students

Where it fits FLI realities well:

  • PSLF fits this field better than most surgical subspecialties. HPB practice is concentrated at academic and nonprofit tertiary hospitals, which are the employers that qualify for Public Service Loan Forgiveness. The long training tail cuts the other way and in your favor here, since residency and fellowship years count toward the 120 qualifying payments. A trainee who starts at a 501(c)(3) residency and stays academic can plausibly reach forgiveness not long after becoming an attending.
  • The pay is solid, and the ceiling is lower than the field's reputation suggests. General surgery at $482,574 is a life-changing income by any FLI measure, and a high-volume HPB practice reaches higher. But transplant surgery is the lowest-paying academic surgical subspecialty in the AAMC data, and the widely circulated $677,000 transplant median came from an aggregator rather than a survey. Plan against the general-surgery figure and treat anything above it as upside.759
  • Job security is genuine. Even in a market its graduates call saturated, 82% of surveyed graduates had one to three offers during fellowship and 75% were still in that first job.6 Saturation here means fewer ideal jobs rather than no jobs.
  • The IMG door is more open than in most surgical subspecialties. Programs that sponsor H-1B and O-1 visas and run dedicated international fellowships are a real feature of this field, which matters if you or your family navigated immigration.1

Risks to name honestly:

  • The training length is the biggest cost, and it is a specifically FLI cost. Fifteen years from the start of college, often more, is fifteen years of trainee income while your family may need help now. The 58% who arrive having already done another fellowship illustrate how easily this stretches.6 If you are the person your family relies on financially, model this against a shorter path before committing, and read the Money section on supporting family during training.
  • Geography is not negotiable, and for many FLI students it is the thing they most want to control. If staying near family in a particular city matters to you, HPB may simply not permit it, because the volume that makes the field safe exists in a limited number of places.
  • Academic capital compounds here. Fellowship selection at a small number of university programs runs on mentorship and research output, which are exactly the resources students without a home HPB division or funded research time have least of. If this field interests you, the practical move is early: find an HPB surgeon at whatever institution you land in, and build the relationship years before you apply.
  • The non-ACGME credential shapes which door you choose. If a formal ABS board certificate matters to you, for job security, for immigration paperwork, or for peace of mind, the CGSO route provides one and the dedicated HPB route does not.12

Bottom line for FLI: HPB offers a strong, secure income, a PSLF-friendly employment base, and an unusually open route for international graduates, in exchange for the longest training tail on the surgical side of the Sky and a career-long constraint on where you can live. Choose it because these operations are the ones you want to spend a life getting good at. The money is real but it is not the reason, and the geography is a cost you will pay every year.

Fun facts

  • The Whipple is named for Allen Whipple, who described the modern two-stage version in 1935. For decades it carried a mortality rate high enough that some surgeons argued it should be abandoned entirely.
  • Where you have the operation matters more than almost anything else about it. In-hospital mortality after pancreaticoduodenectomy ran roughly three times higher at very-low-volume hospitals than at high-volume ones across the periods studied in the landmark analysis, which is why the field pushes so hard for regionalization.3
  • The field has three front doors and no ACGME accreditation on the main one. A dedicated HPB fellowship is accredited by the Fellowship Council and AHPBA, and the certificate process only began in 2010.14
  • The liver has no natural planes. Every "anatomic" liver resection is anatomic by knowledge rather than by appearance, which is why intraoperative ultrasound, performed and interpreted by the surgeon, is a core skill of the field.
  • The field's own trainees think two years is right. In the 2014 AHPBA survey, 68.1% preferred a two-year clinical fellowship with research time, and practicing surgeons agreed at nearly the same rate.4
  • Fellows expect to log more Whipples than they think they need. Respondents put 29 pancreaticoduodenectomies as the threshold for independent practice; trainees reported averaging 38.4

Sources

Footnotes

  1. HPB fellowship structure, accreditation, and application. Cleveland Clinic Hepato-Pancreato-Biliary Fellowship — 2-year fellowship, "Fellowship Council and Americas Hepato-Pancreato-Biliary Association (AHPBA) accredited," appointments made competitively through the Fellowship Council matching system; eligibility requires completion of a US or Canadian general surgery residency, ECFMG certification for foreign graduates, H-1B and O-1 visa sponsorship available; 80% clinical time with open, laparoscopic, and robotic exposure and intraoperative ultrasound. https://my.clevelandclinic.org/departments/digestive/medical-professionals/education/hepatobiliary-fellowship (accessed 2026). ↩ ↩2 ↩3 ↩4 ↩5 ↩6 ↩7 ↩8 ↩9 ↩10 ↩11

  2. The CGSO route and dual certification. Medical College of Wisconsin Hepatopancreaticobiliary Surgery (HPB) Fellowship — the ACGME-accredited Complex General Surgical Oncology fellowship, whose graduates "become eligible for dual certification by pursuing AHPBA HPB Surgery Certification in addition to the American Board of Surgery CGSO Board Certification." https://www.mcw.edu/departments/surgery/education/fellowship-programs/hepatopancreaticobiliary-surgery-hpb-fellowship (accessed 2026). ↩ ↩2 ↩3 ↩4

  3. Volume-outcome relationship in pancreaticoduodenectomy. Ho V, Heslin MJ, Annals of Surgery, April 2003 — 6,652 patients, California and Florida, 1988–1998; volume bands very low (1/yr), low (2–3), medium (4–9), high (10+); in-hospital mortality 14.6% at very-low-volume vs 4.7% at high-volume hospitals (1988–1991) and 9.5% vs 3.3% (1996–1998); hospital procedure volume mattered more than years of surgeon experience. https://pmc.ncbi.nlm.nih.gov/articles/PMC1514467/ ⟳ ↩ ↩2 ↩3

  4. Training pathways, program counts, preferred fellowship length, and case thresholds. Jeyarajah DR et al., "Training and practice of the next generation HPB surgeon: analysis of the 2014 AHPBA residents' and fellows' symposium survey," HPB — 176 responses from 1,231 AHPBA members (14.3%), 86.2% male, 78.8% aged 31–50; ~20 US and 6 Canadian HPB fellowship programs; pathway split surgical oncology 28%, transplant 24.8%, dedicated HPB 24.2%, HPB/complex GI 16%, HPB/MIS 4%; 68.1% preferred a 2-year clinical fellowship with research (67.5% of practicing surgeons agreeing); pancreaticoduodenectomy threshold 29 cases (38 averaged in training), hemi-liver resection 27; AHPBA certificate process initiated 2010. https://pmc.ncbi.nlm.nih.gov/articles/PMC4644361/ ⟳ ↩ ↩2 ↩3 ↩4 ↩5 ↩6 ↩7 ↩8 ↩9 ↩10 ↩11

  5. Compensation for the specialties adjacent to HPB, from the peer-reviewed literature. Kim R, Sheetz KH et al. (as published), "The Passion Tax: Valuation Disparity among Academic and Nonacademic Surgery Subspecialty," Journal of the American College of Surgeons 240(4), April 2025. PMID 40029934, free full text at https://pmc.ncbi.nlm.nih.gov/articles/PMC12060263/ . Source data: MGMA Provider Compensation, calendar years 2014, 2018 and 2022. Mean total cash compensation for 2022 — transplant surgery $557,861 ± 243,687 academic and $603,002 ± 342,906 non-academic; surgical oncology $473,343 ± 202,607 academic and $499,141 ± 217,614 non-academic. Transplant compensation per wRVU rose to $93.51 academic and $102.54 non-academic. Two limits that matter: the study reports no provider counts for any cell, and the non-academic transplant change over the period is not statistically significant (p=0.1518). Neither figure is an HPB figure. Surgical oncology is used here as the closer proxy because 81% of complex general surgical oncology graduates go on to care for HPB patients (PMID 30761439). On Medicare reimbursement for the operations themselves: "Declining Medicare reimbursement in abdominal transplantation, 2000–2021," Surgery 2023, PMID 36894411, puts the inflation-adjusted fall for liver transplant at 32.4%. This footnote previously carried a five-point transplant percentile ladder (10th $550,311 · 25th $610,729 · median $677,090 · 75th $774,539 · 90th $863,261) sourced to Salary.com, a job-posting aggregator on this site's excluded list. It was removed rather than relabeled, because an aggregator's number is not evidence of anything, including of what surgeons report. ⟳ On Salary.com: its CompAnalyst benchmark is HR-reported employer survey data blended with job-posting data, not a physician panel. It is base-weighted and so runs low against total-compensation surveys, and it is used here for percentile structure rather than for levels. ↩ ↩2 ↩3

  6. HPB fellowship graduate outcomes. Jackson T, Lim JS, Cho E, Osman H, Nagatomo K, Jeyarajah DR, "Hepatopancreatobiliary Fellowship Graduates: Where Do They Stand Today?", The American Surgeon 2022;88(6):1250–1255 (online 10 Feb 2021) — 26-question anonymous survey of graduates of accredited HPB fellowships, 2010–2019; 58% had completed a prior fellowship; 82% received 1–3 job offers during fellowship; 75% remained at their first position; >60% secured a job with a >50% HPB practice and >40 HPB cases per year within 3 years; >90% rated training satisfaction above 8/10. https://pubmed.ncbi.nlm.nih.gov/33565895/ ⟳ ↩ ↩2 ↩3 ↩4 ↩5 ↩6

  7. General surgery compensation anchor. Doximity 2025 Physician Compensation Report — ~230,000 survey responses over six years including more than 37,000 US physicians in 2024; average physician compensation up 3.7% from 2023 to 2024; gender pay gap 26% in 2024 (women physicians earning $120,917 less on average); general surgery $482,574, oncology $502,465. https://www.doximity.com/reports/physician-compensation-report/2025 ⟳ ↩ ↩2

  8. Parent-field figures for general surgery. Typical comp ~$440k–$485k, ~60–66 hrs/week with heavy call and low early-career schedule control, and residency attrition ~20%: see the general surgery profile on this site. Burnout: Medscape Physician Burnout & Depression Report 2024, n=9,226, fielded July–October 2023, paywalled and returning HTTP 402, so it reaches this page through three independent relays that agree on the edition, the instrument and every row — Healthgrades Pro (https://resources.healthgrades.com/pro/the-most-and-least-burned-out-physicians-by-specialty) and Advisory Board (https://www.advisory.com/daily-briefing/2024/01/31/physician-burnout). Women in practice: AAMC, "Women are changing the face of medicine in America" (2022 data), https://www.aamc.org/news/women-are-changing-face-medicine-america. Women in training: ACGME, Data Resource Book, Academic Year 2024-2025, Table C.21, https://www.acgme.org/globalassets/pfassets/publicationsbooks/2024-2025_acgme_databook_document.pdf. DO and IMG shares: NRMP, Results and Data: 2026 Main Residency Match, May 2026, Table 2, https://www.nrmp.org/wp-content/uploads/2026/05/Main_Match_Results_and_Data-2026.pdf. One figure here is an instrument choice rather than a source disagreement, and it is named rather than buried. Burnout: this page says ~43.8% for general surgery against an all-physician average of 41.9%, with emergency medicine ~49.8% and urology ~49.5%, which comes from AMA, These 9 physician specialties report highest burnout rates (2025 Organizational Biopsy, ~19,000 responses across 38 states), https://www.ama-assn.org/practice-management/physician-health/these-9-physician-specialties-report-highest-burnout-rates; Medscape 2024 is a separate instrument and puts general surgery at 45% against an all-physician average of 49%, emergency medicine at 63% and urology at 49%. Corrected 2026-08-13: this footnote previously said the 2025 set had no publisher this site could point to. It does, and the general surgery profile cites it. Corrected 2026-08-17: three further figures sat in the body while this note recorded that its own sources said otherwise, so the correction reached the footnote and never reached the reader, including in two dashboard rows. All three are now in the body. Women in practice is AAMC's 24% for general surgery (2022 data), not the ~22.6% previously carried. Women in training is Table C.21's 5,024 of 10,074 surgery residents, 49.9%, not ~45–48%. DO and IMG are the 2026 Match's 344 of 1,804 filled categorical surgery positions (19.1%) and 213 of 1,804 (11.8%), not the ~14.7% and ~12.1% previously quoted. Those two were also mismatched against each other: 14.7% was 2025's US-DO-seniors share on a positions-offered denominator, while 12.1% was 2025's all-IMG share on a positions-filled one, and the true 2025 DO total was 16.8%. Sweeping only the year would have left that mismatch standing. The denominator throughout is now positions filled. Corrected 2026-08-17: the burnout paragraph carried the same 27-word sentence twice in a row, differing only in "either way" versus "too", with this citation marker and a ⟳ stamp sitting between the two copies. The duplicate is deleted. ⟳ ↩ ↩2 ↩3 ↩4 ↩5 ↩6

  9. Academic surgical subspecialty compensation and where transplant sits in it. "Academic Surgeon Financial Compensation in the United States: Trends from 2017 to 2023," Journal of the American College of Surgeons 241(5):864–872, 2025. PMID 40492641, https://pubmed.ncbi.nlm.nih.gov/40492641/ . Source data: the AAMC Faculty Salary Survey, 12,443 academic surgery faculty in 2023 across 11 subspecialties. The full text is paywalled and returns HTTP 402, and the abstract carries no dollar figures, so the finding used here reaches this page through the American College of Surgeons' own Bulletin write-up of the paper (10 September 2025), which states that transplant surgery is the lowest-paying academic surgical subspecialty: https://www.facs.org/for-medical-professionals/news-publications/news-and-articles/bulletin/2025/september-2025-volume-110-issue-8/academic-surgeons-confront-stagnant-pay-persistent-gaps-in-compensation/ No absolute dollar figure for academic transplant surgery is publicly readable. ⟳ ↩ ↩2

  10. The field's assessment of its own training and job market. "AHPBA graduated fellows' assessments of strengths, weaknesses, opportunities and threats facing fellowship training in HPB surgery: 'HPB training excellence means volume, knowledge, and mentorship'," HPB (Oxford) 2022;24(12):2063–2071 — survey of AHPBA-certified fellowship graduates conducted August–December 2021; four dominant themes: lack of standardization between HPB fellowship curricula, job market oversaturation across all three sponsoring societies, the need to articulate the value of HPB fellowship training, and the importance of diversity, inclusion, and equity; strengths named as case volume and technical training. https://pubmed.ncbi.nlm.nih.gov/36333230/ ⟳ ↩ ↩2 ↩3 ↩4 ↩5

Researched with AI assistance and reviewed by hand. How this site is made